The nuclear factor kappa B (NF-κB) signaling pathway is also a key regulator of cancer cell proliferation, progression and metastasis, and activation of NF-κB protein cascade complexes by cytokines has been observed in patients with CRC (60). Here, NFKB1 is linked to cancer.